4
Changes in Ownership
ATOSSA THERAPEUTICS, INC. Filed Acc 0001437749-23-005531
Options or other derivatives
- CFO, Gen Counsel and Secretary acquired 557,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Guse Kyle CFO, Gen Counsel and Secretary | 2023-03-02 | Grant or award · Stock Option (right to buy) | +557,900 | 557,900 | D | ||
Loading xslF345X03/rdgdoc.xml…